Ziliang Dong Selected Research

hexadecylamine

1/2017

Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ziliang Dong Research Topics

Disease

67	Neoplasms (Cancer) 01/2022 - 01/2016
15	Hypoxia (Hypoxemia) 01/2020 - 09/2016
7	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2018
3	Inflammation (Inflammations) 01/2022 - 07/2020
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2020
3	Melanoma (Melanoma, Malignant) 01/2022 - 01/2019
3	Hyperthermia 03/2021 - 10/2017
2	Starvation 01/2020 - 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Atherosclerotic Plaque (Atheroma) 10/2021
1	Atherosclerosis 10/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2021
1	Lung Neoplasms (Lung Cancer) 03/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Rhabdomyolysis 01/2021
1	Cytokine Release Syndrome 07/2020
1	Pneumonia (Pneumonitis) 07/2020
1	Thrombosis (Thrombus) 01/2020

Drug/Important Bio-Agent (IBA)

11	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 01/2016
8	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 11/2018
8	Pharmaceutical PreparationsIBA 01/2022 - 10/2017
8	Photosensitizing Agents (Photosensitizers)IBA 01/2022 - 01/2017
8	PolymersIBA 01/2021 - 01/2017
8	Oxygen (Dioxygen)IBA 09/2019 - 01/2017
7	Immune Checkpoint InhibitorsIBA 01/2022 - 10/2019
6	Proteins (Proteins, Gene)FDA Link 05/2020 - 01/2017
6	Liposomes (Liposome)IBA 01/2019 - 01/2017
6	AlbuminsIBA 12/2018 - 09/2016
5	LipidsIBA 01/2022 - 10/2017
5	phytochlorinIBA 01/2022 - 01/2017
5	CatalaseIBA 01/2022 - 10/2017
4	EnzymesIBA 01/2022 - 10/2017
4	HydrogelsIBA 01/2022 - 06/2019
4	Cancer VaccinesIBA 11/2021 - 01/2019
4	Therapeutic UsesIBA 01/2020 - 01/2016
4	Chelating AgentsIBA 11/2018 - 01/2017
3	IronIBA 01/2022 - 10/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2018
3	NanovaccinesIBA 11/2021 - 01/2019
3	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 10/2021 - 01/2016
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 03/2021 - 01/2016
3	AntigensIBA 01/2020 - 01/2017
3	Radioisotopes (Radionuclides)IBA 01/2019 - 01/2017
3	Singlet OxygenIBA 05/2018 - 11/2017
2	KynurenineIBA 01/2022 - 11/2020
2	AlginatesIBA 01/2022 - 01/2018
2	Biocompatible Materials (Biomaterials)IBA 01/2022 - 06/2020
2	ChitosanIBA 01/2022 - 01/2020
2	VaccinesIBA 11/2021 - 01/2020
2	CPG-oligonucleotideIBA 11/2021 - 01/2018
2	MetalsIBA 10/2021 - 11/2020
2	CypateIBA 03/2021 - 01/2020
2	IonsIBA 11/2020 - 01/2016
2	Hydroxyl RadicalIBA 01/2020 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2018
2	SolutionsIBA 06/2019 - 08/2018
2	vanadium disulfideIBA 07/2018 - 10/2017
2	ProdrugsIBA 01/2018 - 01/2017
2	AQ4NIBA 01/2018 - 01/2017
1	Protons (Proton)IBA 01/2022
1	Lipid PeroxidesIBA 01/2022
1	Firefly LuciferasesIBA 01/2022
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 01/2022
1	D-luciferinIBA 01/2022
1	Superoxide DismutaseIBA 01/2022
1	AntioxidantsIBA 01/2022
1	LigandsIBA 01/2022
1	Cell Adhesion MoleculesIBA 11/2021
1	Toll-Like Receptor 9IBA 11/2021
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 11/2021
1	Apolipoproteins E (ApoE)IBA 10/2021
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 10/2021
1	polymethacrylic acid (PMAA)IBA 03/2021
1	CurcuminIBA 01/2021
1	Biological ProductsIBA 01/2021
1	OvalbuminIBA 12/2020
1	Fluorocarbon PolymersIBA 12/2020
1	diazonaphthalenedisulfonic acid (NDS)IBA 11/2020
1	titanium dioxide (Titania)FDA Link 11/2020
1	2- ((aminocarbonyl)amino)- 5- (4- fluorophenyl)- 3- thiophenecarboxamideIBA 07/2020
1	ThiophenesIBA 07/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2020
1	Horseradish PeroxidaseIBA 01/2020
1	Glucose OxidaseIBA 01/2020
1	Gallic AcidIBA 01/2020

Therapy/Procedure

40	Therapeutics 01/2022 - 01/2016
20	Intravenous Injections 01/2022 - 01/2016
18	Precision Medicine 01/2022 - 01/2016
16	Radiotherapy 01/2022 - 01/2016
12	Drug Therapy (Chemotherapy) 01/2022 - 09/2016
11	Immunotherapy 01/2022 - 01/2017
11	Photochemotherapy (Photodynamic Therapy) 01/2022 - 01/2017
8	Photothermal Therapy 01/2022 - 01/2016
6	Lasers (Laser) 01/2022 - 02/2016
2	Intravenous Administration 10/2021 - 03/2021
2	Phototherapy (Light Therapy) 01/2018 - 01/2017
2	Aftercare (After-Treatment) 10/2017 - 01/2017
1	Radiofrequency Ablation 01/2021
1	Injections 06/2020
1	Radioimmunotherapy 04/2020